| 產品名稱 |
Rotavirus reassortant |
| 商品貨號 |
B184400 |
| Classification |
Reoviridae, Rotavirus |
| Agent |
Rotavirus reassortant |
| Strain |
HCR3a |
| Applications |
vaccine production |
| Biosafety Level |
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Isolation |
stool from a human infant 3 days after oral administration of bovine rotavirus vaccine WC3 |
| Product Format |
frozen |
| Storage Conditions |
-70°C |
| Disclosure |
This material is cited in a US or other Patent and may not be used to
infringe the claims. Depending on the wishes of the Depositor, ATCC may be
required to inform the Patent Depositor of the party to which the material was
furnished. This material may not have been produced or characterized by ATCC. |
| Comments |
may cause gastroenteritis in infants -70C Propagate in cell culture with serum-free media with 0.5 ug/ml trypsin. serotype 3, subgroup 1 |
| Effect on Host |
Yes, in vitro effects: vague CPE (rounding and cell detachment) Vague CPE; rounding and cell detachment |
| Recommended Host |
MA-104 cells (ATCC CRL-2378) Host of Choice:? MA-104 (CRL-2378) Host Range: MA-104, CV-1, Vero MA-104 cells (ATCC CRL-2378); CV-1 cells (ATCC CCL-70); Vero cells (ATCC CCL-81) |
| Growth Conditions |
Duration: 3-8 days at 37C |
| Cryopreservation |
Storage temperature: -70C |
| Name of Depositor |
Wistar Institute of Anatomy and Biology |
| U.S. Patent |
|
| U.S. Patent Number |
|
| Special Collection |
NCRR Contract |
| Source |
stool from a human infant 3 days after oral administration of bovine rotavirus vaccine WC3 |
| References |
Clark HF. Human rotavirus HCR3a and method of growing said rotavirus. US Patent 5,610,049 dated Mar 11 1997
|
